At Neuro-Behavioral Clinical Research, we're honored to have played a part in something meaningful for the future of anxiety treatment. Definium Therapeutics has just announced positive results from the Panorama study, a Phase 3 clinical trial evaluating a new investigational treatment for Generalized Anxiety Disorder (GAD), commonly known simply as anxiety. This is the third consecutive positive Phase 3 result for this treatment, following earlier successful studies in both